I just found an Article in JAMA (the Journal of the American Medical Association), dated June 21, 2021, by WK Silverstein and D. Grady, entitled “Overuse of Levothyroxine in Patients With Subclinical Hypothyroidism: Time to “Leve”-Out-Thyroxine“.
The abstract (the summary) of this article reads as follows:
“Recent clinical trials and a meta-analysis demonstrate no symptomatic benefit from treatment with levothyroxine among nonpregnant adults with subclinical hypothyroidism ……. Contemporary evidence-based clinical practice guidelines strongly advise against levothyroxine (ELTROXIN or SYTHROID) supplementation for subclinical hypothyroidism …. (and) …. older guidelines from professional societies generally do not recommend treatment for subclinical hypothyroidism.”
This sort of information is very important to many of you, especially the people who are unhappy about being treated with Eltroxin or Synthroid and I would love to write a post about it.
So here’s the problem: JAMA, like many journals, especially those which belong to big online “libraries”, charges fees to allow access to articles. If I were working at a teaching hospital or a university, my institution would pay these fees, but I am not.
As a “standalone” researcher I could buy the article for US$40, or I could join an outfit called “DeepDyve” for US$499 per year.
That doesn’t sound like such a lot, but here, I am talking about one single article! If I am going to do that sort of thing, I would need to join four or five other libraries so as to access articles which I should read so as to give you the cogent information which I would like to provide.
Frankly, such sums are not available to me.
Funds donated to this website will be applied to cover the costs involved in acquisition of information you need.
So …… ?
With my thanks, in advance, and with my best wishes, for 2022 !
Gervais A. Harry.